Implants

Agile Sees Renewed Hope For Even Broader Adoption Of Its Weekly Birth Control Patch After Biden’s Latest Executive Order Expanding Contraceptive Coverage

PRINCETON, NJ / ACCESSWIRE / July 11, 2023 / - In June, President Biden issued an Executive Order on Strengthening…

1 year ago

Safe group group reports half-year revenues of €2.9m

                                                                                                                                                    Safe group group reports half-year revenues of €2.9m      Second-quarter revenue of €1.4M in Q2 2022, stable compared with Q1…

1 year ago

Aurora Spine Announces Initial Patient Enrolled for DEXA-CTM Multicenter Study

Carlsbad, Calif, June 28, 2023 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV:ASG) (OTCQB: ASAPF), a…

1 year ago

OrthoPediatrics Corp. Announces the Launch and First Case Using the GIRO™ Growth Modulation System

WARSAW, Ind., June 27, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively…

1 year ago

Femasys Announces FDA Approval of its IDE for the Pivotal Clinical Trial of FemBloc Permanent Birth Control, a Non-Surgical Alternative for Women

- Pivotal clinical trial to begin in the third quarter of 2023 - ATLANTA, June 26, 2023 (GLOBE NEWSWIRE) --…

1 year ago

Sientra Announces Appointment of Alexander W. Casdin to Board of Directors

IRVINE, Calif., June 20, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company…

1 year ago

Lyra Therapeutics to Present at Jefferies Healthcare Conference

WATERTOWN, Mass., June 02, 2023 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage biotechnology company developing innovative therapies…

1 year ago

Mithra Appoints Experienced Life Sciences Executive Christian Homsy* as Chairman

Inge Beernaert appointed President of the Compensation and Nomination CommitteeJacques Galloy appointed President of the Audit CommitteeLiege, Belgium, 29 May…

1 year ago

Lyra Therapeutics Announces $50.0 Million Private Placement

WATERTOWN, Mass., May 26, 2023 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA) (“Lyra” or the “Company”), a clinical-stage biotechnology…

2 years ago